Newswise News from Fundació Institut de Recerca Biomèdica (IRB BARCELONA) display Latest news from Fundació Institut de Recerca Biomèdica (IRB BARCELONA) on Newswise en-us Copyright 2024 Newswise Newswise News from Fundació Institut de Recerca Biomèdica (IRB BARCELONA) 115 31 / /images/newswise-logo-rss.gif Synchronisation between the central circadian clock and the circadian clocks of tissues preserves their functioning and prevents ageing /articles/synchronisation-between-the-central-circadian-clock-and-the-circadian-clocks-of-tissues-preserves-their-functioning-and-prevents-ageing/?sc=rsin /articles/synchronisation-between-the-central-circadian-clock-and-the-circadian-clocks-of-tissues-preserves-their-functioning-and-prevents-ageing/?sc=rsin Thu, 02 May 2024 14:00:00 EST * Two complementary research articles, published simultaneously in the journals Science and Cell Stem Cell by a team of scientists from the UPF and IRB Barcelona, reveal that central and peripheral circadian clocks coordinate to regulate the daily activity of skin and muscles. * The coordination between the two clocks (central and peripheral) guarantees 50% of the circadian functions of tissues, including vital processes such as the cell cycle, DNA repair, mitochondrial activity, and metabolism. * Synchronisation between the central brain clock and peripheral ones prevents premature muscle ageing and improves muscle function, suggesting new strategies to tackle age-related decline through circadian rhythm modulation. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Researchers observe at the atomic level the neuronal 'gate' for essential molecules in learning and memory /articles/researchers-observe-at-the-atomic-level-the-neuronal-gate-for-essential-molecules-in-learning-and-memory/?sc=rsin /articles/researchers-observe-at-the-atomic-level-the-neuronal-gate-for-essential-molecules-in-learning-and-memory/?sc=rsin Wed, 17 Apr 2024 04:05:48 EST The protein Asc-1 serves as the gateway (either for entry or exit) for fundamental amino acids involved in cognitive processes. A new study now unveils its structure and mechanism of action. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Characterization of mutational "coldspots" in the cancer genome /articles/characterization-of-mutational-coldspots-in-the-cancer-genome/?sc=rsin /articles/characterization-of-mutational-coldspots-in-the-cancer-genome/?sc=rsin Wed, 10 Apr 2024 09:05:07 EST Researchers at IRB Barcelona report mutation rate variation across the human genome. Regions with low mutation rates correlate with hypomethylation (low methylation levels), a way cells control which genes are turned on or off. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Researchers from IRB Barcelona and Sant Joan de Deu unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues /articles/researchers-from-irb-barcelona-and-sant-joan-de-d-u-unveil-the-origin-of-second-pediatric-cancers-and-chemotherapy-induced-mutations-in-healthy-tissues/?sc=rsin /articles/researchers-from-irb-barcelona-and-sant-joan-de-d-u-unveil-the-origin-of-second-pediatric-cancers-and-chemotherapy-induced-mutations-in-healthy-tissues/?sc=rsin Tue, 19 Mar 2024 10:00:00 EST A team from IRB Barcelona and Sant Joan de Deu Hospital (mid dot) IRSJD has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second tumour. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Launch of a pioneering translational research programme in Europe /articles/aunch-of-a-pioneering-translational-research-programme-in-europe/?sc=rsin /articles/aunch-of-a-pioneering-translational-research-programme-in-europe/?sc=rsin Wed, 06 Mar 2024 08:05:39 EST - The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients. - TRIP will focus on emerging fields such as immuno-oncology, inflammation, and cellular senescence. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) New drug reveals a key mechanism to overcome resistance to protein degraders /articles/new-drug-reveals-a-key-mechanism-to-overcome-resistance-to-protein-degraders/?sc=rsin /articles/new-drug-reveals-a-key-mechanism-to-overcome-resistance-to-protein-degraders/?sc=rsin Tue, 30 Jan 2024 06:05:09 EST Protein degraders offer a novel approach to targeting undruggable diseases by hijacking the cell's degradation machinery. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Chemotherapy becomes more efficient when senescent cells are eliminated by immunotherapy /articles/chemotherapy-becomes-more-efficient-when-senescent-cells-are-eliminated-by-immunotherapy/?sc=rsin /articles/chemotherapy-becomes-more-efficient-when-senescent-cells-are-eliminated-by-immunotherapy/?sc=rsin Wed, 24 Jan 2024 05:00:00 EST Researchers from IRB Barcelona describe a mechanism by which senescent cells generated by chemotherapy survive inside tumours. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Bladder tumours reduced by 90% using nanorobots /articles/bladder-tumours-reduced-by-90-using-nanorobots/?sc=rsin /articles/bladder-tumours-reduced-by-90-using-nanorobots/?sc=rsin Mon, 15 Jan 2024 07:05:11 EST The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Candida evolution disclosed: new insights into fungal infections /articles/candida-evolution-disclosed-new-insights-into-fungal-infections/?sc=rsin /articles/candida-evolution-disclosed-new-insights-into-fungal-infections/?sc=rsin Fri, 12 Jan 2024 05:00:00 EST Identification of genes under recent selection provides insights into the molecular mechanisms of human-related adaptation in Candida pathogens. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Unravelling individual differences in DNA mutation risks /articles/unravelling-individual-differences-in-dna-mutation-risks/?sc=rsin /articles/unravelling-individual-differences-in-dna-mutation-risks/?sc=rsin Wed, 10 Jan 2024 05:00:00 EST Researchers at IRB Barcelona discover unexpected patterns in mutation risks across individuals, uncovering 13 distinct genomic patterns. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Iron accumulation: a new insight into fibrotic diseases /articles/iron-accumulation-a-new-insight-into-fibrotic-diseases/?sc=rsin /articles/iron-accumulation-a-new-insight-into-fibrotic-diseases/?sc=rsin Thu, 14 Dec 2023 05:00:00 EST * Researchers at IRB Barcelona reveal the pivotal role of iron accumulation in the development of fibrotic diseases and propose that iron detection via MRI can serve to diagnose fibrosis. * Fibrotic diseases account for 45% of all mortality in developed countries. * Published in Nature Metabolism, the study points to new therapeutic opportunities that target iron. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer /articles/hard-to-drug-protein-droplets-reveal-new-ways-to-inhibit-transcription-factors-in-an-aggressive-form-of-prostate-cancer/?sc=rsin /articles/hard-to-drug-protein-droplets-reveal-new-ways-to-inhibit-transcription-factors-in-an-aggressive-form-of-prostate-cancer/?sc=rsin Mon, 04 Dec 2023 11:00:00 EST Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) A change in rigidity switches the function of protein condensates involved in sensing touch /articles/a-change-in-rigidity-switches-the-function-of-protein-condensates-involved-in-sensing-touch/?sc=rsin /articles/a-change-in-rigidity-switches-the-function-of-protein-condensates-involved-in-sensing-touch/?sc=rsin Sun, 22 Oct 2023 16:05:10 EST A team of researchers describes in Nature Cell Biology the mechanism by which the MEC-2 protein condensates of the touch receptor neurons transition from fluid to solid-like states, switching their role in the transmission of mechanical forces. These findings pave the way for developing innovative therapies and treatments. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients /articles/palex-and-inbiomotion-introduce-pioneering-test-to-aid-oncologists-in-predicting-recurrence-and-survival-rates-in-breast-cancer-patients/?sc=rsin /articles/palex-and-inbiomotion-introduce-pioneering-test-to-aid-oncologists-in-predicting-recurrence-and-survival-rates-in-breast-cancer-patients/?sc=rsin Fri, 29 Sep 2023 08:05:10 EST Spain is the first country in the world to have this technology * Results showing the clinical utility of the test were published in Lancet Oncology and the Journal of National Cancer Institute * The test is now available to oncologists and pathologists and will benefit an estimated 24,000 patients each year in Spain Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Chromosomal instability in cancer cells causes DNA damage and promotes invasiveness /articles/chromosomal-instability-in-cancer-cells-causes-dna-damage-and-promotes-invasiveness/?sc=rsin /articles/chromosomal-instability-in-cancer-cells-causes-dna-damage-and-promotes-invasiveness/?sc=rsin Tue, 26 Sep 2023 04:00:24 EST Chromosomal instability is a phenomenon characterised by rapid changes in the number and structure of chromosomes during cell division. It is very common in solid tumours and it is linked to the aggressive spread of cancer, that is to say, metastasis. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) A medication used for heart conditions improves the efficacy of current treatments for melanoma /articles/a-medication-used-for-heart-conditions-improves-the-efficacy-of-current-treatments-for-melanoma/?sc=rsin /articles/a-medication-used-for-heart-conditions-improves-the-efficacy-of-current-treatments-for-melanoma/?sc=rsin Thu, 10 Aug 2023 11:00:00 EST A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d'Alacant, Valencian Community) and IRB Barcelona (Barcelona, Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Gene editing via CRISPR/Cas9 can lead to cell toxicity and genome instability /articles/gene-editing-via-crisprcas9-can-lead-to-cell-toxicity-and-genome-instability/?sc=rsin /articles/gene-editing-via-crisprcas9-can-lead-to-cell-toxicity-and-genome-instability/?sc=rsin Tue, 09 Aug 2022 13:05:12 EST Researchers at IRB Barcelona identify critical spots on the genome where gene editing could cause an unwanted response, and they provide recommendations for safer approaches. Fundacio Institut de Recerca Biomedica (IRB BARCELONA) Hereditary factors that increase the likelihood of cancer mutations detailed in new study /articles/hereditary-factors-that-increase-the-likelihood-of-cancer-mutations-detailed-in-new-study/?sc=rsin /articles/hereditary-factors-that-increase-the-likelihood-of-cancer-mutations-detailed-in-new-study/?sc=rsin Tue, 05 Jul 2022 14:15:01 EST Mutations occur in various tissues and organs of an individual. Somatic mutations occur in cells that will not give rise to offspring and are therefore not passed on to subsequent generations. Fundacio Institut de Recerca Biomedica (IRB BARCELONA)